|
sulforaphane Clinical Trials
1 actively recruiting trial across 1 location
▼ -1 trial since June 2026
Also known as: Avmacol Extra Strength
Pipeline
Phase 1/2: 1
Top Sponsors
- Texas Tech University Health Sciences Center1
Indications
- Anthracycline Related Cardiotoxicity in Breast Cancer1
- Heart Disease1
- Breast Cancer1
- Cancer1
Lubbock, Texas1 trial
Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction
Texas Tech University Health Sciences Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.